Endovascular recanalization for chronic symptomatic middle cerebral artery total occlusion
The optimal treatment of chronic middle cerebral artery (MCA) occlusion is unclear. Angioplasty and stenting may be an alternative treatment for patients with recurrent ischemic symptoms despite medical therapy. Two patients with chronic right MCA occlusion successfully treated with stenting are rep...
Main Authors: | , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
BMJ Group
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623035/ |
id |
pubmed-3623035 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-36230352013-04-11 Endovascular recanalization for chronic symptomatic middle cerebral artery total occlusion Ma, Ning Mo, Da-Peng Gao, Feng Miao, Zhong-Rong Electronic Pages The optimal treatment of chronic middle cerebral artery (MCA) occlusion is unclear. Angioplasty and stenting may be an alternative treatment for patients with recurrent ischemic symptoms despite medical therapy. Two patients with chronic right MCA occlusion successfully treated with stenting are reported, together with their long term follow-up to illustrate the feasibility of endovascular recanalization. One patient remained asymptomatic at the 29-month follow-up. Another patient developed symptomatic in-stent restenosis at 12 months which resolved after repeat angioplasty. Further larger scale pilot studies are needed to determine the efficacy and long term outcome of this treatment. BMJ Group 2013-05 2012-04-11 /pmc/articles/PMC3623035/ /pubmed/22496065 http://dx.doi.org/10.1136/neurintsurg-2012-010304 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/3.0/ and http://creativecommons.org/licenses/by-nc/3.0/legalcode |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Ma, Ning Mo, Da-Peng Gao, Feng Miao, Zhong-Rong |
spellingShingle |
Ma, Ning Mo, Da-Peng Gao, Feng Miao, Zhong-Rong Endovascular recanalization for chronic symptomatic middle cerebral artery total occlusion |
author_facet |
Ma, Ning Mo, Da-Peng Gao, Feng Miao, Zhong-Rong |
author_sort |
Ma, Ning |
title |
Endovascular recanalization for chronic symptomatic middle cerebral artery total occlusion |
title_short |
Endovascular recanalization for chronic symptomatic middle cerebral artery total occlusion |
title_full |
Endovascular recanalization for chronic symptomatic middle cerebral artery total occlusion |
title_fullStr |
Endovascular recanalization for chronic symptomatic middle cerebral artery total occlusion |
title_full_unstemmed |
Endovascular recanalization for chronic symptomatic middle cerebral artery total occlusion |
title_sort |
endovascular recanalization for chronic symptomatic middle cerebral artery total occlusion |
description |
The optimal treatment of chronic middle cerebral artery (MCA) occlusion is unclear. Angioplasty and stenting may be an alternative treatment for patients with recurrent ischemic symptoms despite medical therapy. Two patients with chronic right MCA occlusion successfully treated with stenting are reported, together with their long term follow-up to illustrate the feasibility of endovascular recanalization. One patient remained asymptomatic at the 29-month follow-up. Another patient developed symptomatic in-stent restenosis at 12 months which resolved after repeat angioplasty. Further larger scale pilot studies are needed to determine the efficacy and long term outcome of this treatment. |
publisher |
BMJ Group |
publishDate |
2013 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623035/ |
_version_ |
1611969410336030720 |